ID: ALA3883438

Max Phase: Preclinical

Molecular Formula: C24H36N2O5

Molecular Weight: 432.56

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCCC[C@H](NC(=O)C(=O)CCCCc1ccccc1)C(=O)NCC(=O)OC(C)(C)C

Standard InChI:  InChI=1S/C24H36N2O5/c1-5-6-15-19(22(29)25-17-21(28)31-24(2,3)4)26-23(30)20(27)16-11-10-14-18-12-8-7-9-13-18/h7-9,12-13,19H,5-6,10-11,14-17H2,1-4H3,(H,25,29)(H,26,30)/t19-/m0/s1

Standard InChI Key:  BVTSAEBTMZEGOX-IBGZPJMESA-N

Associated Targets(Human)

Phospholipase A2 group V 238 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cytosolic phospholipase A2 785 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Phospholipase A2 group 1B 51 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 432.56Molecular Weight (Monoisotopic): 432.2624AlogP: 3.10#Rotatable Bonds: 13
Polar Surface Area: 101.57Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.97CX Basic pKa: CX LogP: 4.20CX LogD: 4.20
Aromatic Rings: 1Heavy Atoms: 31QED Weighted: 0.28Np Likeness Score: -0.14

References

1. Smyrniotou A, Kokotou MG, Mouchlis VD, Barbayianni E, Kokotos G, Dennis EA, Constantinou-Kokotou V..  (2017)  2-Oxoamides based on dipeptides as selective calcium-independent phospholipase A2 inhibitors.,  25  (3): [PMID:28034646] [10.1016/j.bmc.2016.12.007]

Source